Literature DB >> 31981080

SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019).

A J Muñoz Martín1, E Gallardo Díaz2, I García Escobar3, R Macías Montero4, V Martínez-Marín5, V Pachón Olmos6, P Pérez Segura7, T Quintanar Verdúguez8, M Salgado Fernández9.   

Abstract

In 2011, the Spanish Society of Medical Oncology (SEOM) first published a clinical guideline of venous thromboembolism (VTE) and cancer. This guideline was updated in 2014, and since then, multiple studies and clinical trials have changed the landscape of the treatment and prophylaxis of VTE in cancer patients. To incorporate the most recent evidence, including data from direct oral anticoagulants (DOACs) randomized clinical trials, SEOM presents a new update of the guideline.

Entities:  

Keywords:  Anticoagulation; Cancer; Direct oral anticoagulants; Guideline; Low-molecular-weight heparins; Venous thromboembolism

Year:  2020        PMID： 31981080     DOI： 10.1007/s12094-019-02263-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


  86 in total

1.  Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies.

Authors:  W Saber; T Moua; E C Williams; M Verso; G Agnelli; S Couban; A Young; M De Cicco; R Biffi; C J van Rooden; M V Huisman; D Fagnani; C Cimminiello; M Moia; M Magagnoli; S P Povoski; S F Malak; A Y Lee
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

2.  Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial.

Authors:  Guy Meyer; Benjamin Besse; Hélène Doubre; Anaïs Charles-Nelson; Sandro Aquilanti; Armine Izadifar; Reza Azarian; Isabelle Monnet; Corinne Lamour; Renaud Descourt; Gérard Oliviero; Laurent Taillade; Christos Chouaid; Frederique Giraud; Pierre-Emmanuel Falcoz; Marie-Pierre Revel; Virginie Westeel; Adrien Dixmier; Jean Tredaniel; Stéphanie Dehette; Chantal Decroisette; Alain Prevost; Eric Pichon; Elizabeth Fabre; Jean-Charles Soria; Sylvie Friard; Jean-Baptiste Stern; Laurence Jabot; Georges Dennewald; Gérard Pavy; Patrick Petitpretz; Jean-Marc Tourani; Marco Alifano; Gilles Chatellier; Philippe Girard
Journal:  Eur Respir J       Date:  2018-10-04       Impact factor: 16.671

3.  ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS).

Authors:  Rita Chiari; Biagio Ricciuti; Lorenza Landi; Anna M Morelli; Angelo Delmonte; Gianluca Spitaleri; Diego L Cortinovis; Giuseppe Lamberti; Francesco Facchinetti; Sara Pilotto; Claudio Verusio; Antonio Chella; Laura Bonanno; Domenico Galetta; Federico Cappuzzo
Journal:  Clin Lung Cancer       Date:  2019-06-18       Impact factor: 4.785

4.  Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer.

Authors:  Marc Carrier; Alok A Khorana; Patricia Moretto; Grégoire Le Gal; Rebecca Karp; Jeffrey I Zwicker
Journal:  Am J Med       Date:  2013-10-05       Impact factor: 4.965

Review 5.  Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.

Authors:  Lara A Kahale; Maram B Hakoum; Ibrahim G Tsolakian; Charbel F Matar; Maddalena Barba; Victor E D Yosuico; Irene Terrenato; Francesca Sperati; Holger Schünemann; Elie A Akl
Journal:  Cochrane Database Syst Rev       Date:  2017-12-29

6.  A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.

Authors:  J I Zwicker; R Karp Leaf; M Carrier
Journal:  J Thromb Haemost       Date:  2016-07-29       Impact factor: 5.824

7.  A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer.

Authors:  Maria Cristina Vedovati; Cecilia Becattini; Fabio Rondelli; Michela Boncompagni; Giuseppe Camporese; Ruben Balzarotti; Enrico Mariani; Otello Flamini; Salvatore Pucciarelli; Annibale Donini; Giancarlo Agnelli
Journal:  Ann Surg       Date:  2014-04       Impact factor: 12.969

8.  Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors:  Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

9.  Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.

Authors:  Seth Felder; Morten Schnack Rasmussen; Ray King; Bradford Sklow; Mary Kwaan; Robert Madoff; Christine Jensen
Journal:  Cochrane Database Syst Rev       Date:  2019-03-27

10.  Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).

Authors:  Annie M Young; Andrea Marshall; Jenny Thirlwall; Oliver Chapman; Anand Lokare; Catherine Hill; Danielle Hale; Janet A Dunn; Gary H Lyman; Charles Hutchinson; Peter MacCallum; Ajay Kakkar; F D Richard Hobbs; Stavros Petrou; Jeremy Dale; Christopher J Poole; Anthony Maraveyas; Mark Levine
Journal:  J Clin Oncol       Date:  2018-05-10       Impact factor: 44.544
View more
  7 in total

1.  2019 SEOM guidelines (the end of a decade).

Authors:  A González-Del-Alba; Á Rodríguez-Lescure
Journal:  Clin Transl Oncol       Date:  2020-02-06       Impact factor: 3.405

Review 2.  Update on Guidelines for the Management of Cancer-Associated Thrombosis.

Authors:  Michael B Streiff; Syed Ali Abutalib; Dominique Farge; Martina Murphy; Jean M Connors; Gregory Piazza
Journal:  Oncologist       Date:  2020-12-04

Review 3.  A Systematic Review of the Guidelines on Venous Thromboembolism Prophylaxis in Gynecologic Oncology.

Authors:  Federico Romano; Giovanni Di Lorenzo; Guglielmo Stabile; Mariateresa Mirandola; Stefano Restaino; Patrizia Ianniello; Giuseppe Mirenda; Giuseppe Ricci
Journal:  Cancers (Basel)       Date:  2022-05-15       Impact factor: 6.575

4.  Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study).

Authors:  Remedios Otero; Aurora Solier-López; Verónica Sánchez-López; Julia Oto; Elena Arellano; Samira Marín; Luis Jara-Palomares; Teresa Elías; María Isabel Asencio; Isabel Blasco-Esquivias; María Rodríguez de la Borbolla; José María Sánchez-Díaz; Macarena Real-Domínguez; Emilio García-Cabrera; Francisco Javier Rodríguez-Martorell; Pilar Medina
Journal:  Cancers (Basel)       Date:  2022-06-02       Impact factor: 6.575

5.  Venous Thromboembolism In Cancer Patients: "From Evidence to Care".

Authors:  Mercedes Salgado; Elena Brozos-Vázquez; Begoña Campos; Paula González-Villarroel; María Eva Pérez; María Lidia Vázquez-Tuñas; David Arias
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

6.  Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism.

Authors:  Pedro Ruiz-Artacho; Ramón Lecumberri; Javier Trujillo-Santos; Carme Font; Juan J López-Núñez; María Luisa Peris; Carmen Díaz Pedroche; José Luis Lobo; Luciano López Jiménez; Raquel López Reyes; Luis Jara Palomares; José María Pedrajas; Isabelle Mahé; Manuel Monreal
Journal:  Cancers (Basel)       Date:  2022-08-26       Impact factor: 6.575

7.  Characteristics and predictors of venous thrombosis recurrence in patients with cancer and catheter-related thrombosis.

Authors:  Demis N Lipe; Aiham Qdaisat; Eva Rajha; Aisha Al-Breiki; Maria T Cruz Carreras; Patrick Chaftari; Sai-Ching J Yeung; Terry W Rice
Journal:  Res Pract Thromb Haemost       Date:  2022-08-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.